All enrolled clients who gained not less than one dose of zosuquidar or placebo through induction ended up monitored to the event of adverse situations (439 clients, 219 on zosuquidar and 210 on placebo). The most typical adverse situations ended up connected with the period of extended and considerable myelosuppression https://garrettcnygp.designertoblog.com/59549375/a-review-of-paniculoside-i